Rifampin 600 mg per 10 mL injection, powder, lyophilized, for solution

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Mylan Institutional LLC names for other drugs.

Recalls

• Apr 7, 2022 · Class II · Mylan Pharmaceuticals Inc
  Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
  Lots: Lot #: 7008990, exp. date Dec-2022; 7009025, exp. date Feb-2023; 7009085, 7009086, exp. date Apr-2023
• Oct 7, 2019 · Class II · Mylan Laboratories Limited (Sterile Products Division)
  Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
  Lots: Lot: 7008334, Exp April 2020; 7008417, Exp Oct 2020

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Rifampin: every company that makes it

Form

injection, powder, lyophilized, for solution, intravenous

Strength

600 mg per 10 mL

Approval

ANDA ANDA065421

On the market since

Jan 21, 2015

Package NDCs

67457-445-60

Official label

DailyMed (National Library of Medicine), updated May 5, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?